Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1808030
UPPER GASTROINTESTINAL TRACT TUMORS (STOMACH, ESOPHAGUS, PANCREAS, LIVER, BILIARY TRACT, DUODENUM)
1775
POSTER PRESENTATION

Neoadjuvant folfirinox (FFX) vs. Upfront surgery (US) for pancreatic cancer: a systematic review and meta-analysis

Authors

  • Gabriele Eckerdt Lech

  • Ana Paula Valério Alves

  • Caio Leonardo dos Santos Saggin

  • Camila Mariana de Paiva Reis

  • Raquel Oliveira de Sousa Silva

  • Bernard Giancristoforo Campos

  • Rafael Morriello

Further Information
  All articles of this category

Keywords

pancreatic cancer - folfirinox - neoadjuvant - resectable pancreatic cancer - borderline pancreatic cancer


Publication History

Article published online:
06 May 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

Bibliographical Record
Gabriele Eckerdt Lech, Ana Paula Valério Alves, Caio Leonardo dos Santos Saggin, Camila Mariana de Paiva Reis, Raquel Oliveira de Sousa Silva, Bernard Giancristoforo Campos, Rafael Morriello. Neoadjuvant folfirinox (FFX) vs. Upfront surgery (US) for pancreatic cancer: a systematic review and meta-analysis. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1808030